10-67884727-G-A
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM2BP4_ModerateBP6_ModerateBP7
The NM_012238.5(SIRT1):c.6G>A(p.Ala2Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000371 in 1,076,870 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000037 ( 0 hom. )
Consequence
SIRT1
NM_012238.5 synonymous
NM_012238.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.31
Publications
0 publications found
Genes affected
SIRT1 (HGNC:14929): (sirtuin 1) This gene encodes a member of the sirtuin family of proteins, homologs to the yeast Sir2 protein. Members of the sirtuin family are characterized by a sirtuin core domain and grouped into four classes. The functions of human sirtuins have not yet been determined; however, yeast sirtuin proteins are known to regulate epigenetic gene silencing and suppress recombination of rDNA. Studies suggest that the human sirtuins may function as intracellular regulatory proteins with mono-ADP-ribosyltransferase activity. The protein encoded by this gene is included in class I of the sirtuin family. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.28).
BP6
Variant 10-67884727-G-A is Benign according to our data. Variant chr10-67884727-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 2045818.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=3.31 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SIRT1 | NM_012238.5 | c.6G>A | p.Ala2Ala | synonymous_variant | Exon 1 of 9 | ENST00000212015.11 | NP_036370.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome AF: 0.00000371 AC: 4AN: 1076870Hom.: 0 Cov.: 31 AF XY: 0.00000197 AC XY: 1AN XY: 508512 show subpopulations
GnomAD4 exome
AF:
AC:
4
AN:
1076870
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
508512
show subpopulations
African (AFR)
AF:
AC:
0
AN:
22784
American (AMR)
AF:
AC:
0
AN:
8338
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
14242
East Asian (EAS)
AF:
AC:
0
AN:
26406
South Asian (SAS)
AF:
AC:
0
AN:
19356
European-Finnish (FIN)
AF:
AC:
0
AN:
21080
Middle Eastern (MID)
AF:
AC:
0
AN:
2930
European-Non Finnish (NFE)
AF:
AC:
1
AN:
918296
Other (OTH)
AF:
AC:
3
AN:
43438
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.413
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Dec 28, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.